🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Takashi Miwa

Translational Therapeutics (United States)

ORCID: 0000-0001-7004-4031

Also affiliated with University of Pennsylvania

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “MASP3 Deficiency in Mice Reduces but Does Not Abrogate Alternative Pathway Complement Activity Due to Intrinsic Profactor D Activity”.

MASP3 Deficiency in Mice Reduces but Does Not Abrogate Alternative Pathway Complement Activity Due to Intrinsic Profactor D Activity

The Journal of Immunology(2023)10.4049/jimmunol.2200932

N/A

0DataRank · unranked

8 citations

Takashi Miwa, Madhu Golla, Sayaka Sato, Sree Angampalli, Wen‐Chao Song +1 more

Therapeutic targeting of factor D and MASP3 in complement‐mediated diseases: Lessons learned from mouse studies

European Journal of Immunology(2024)10.1002/eji.202350845

N/A

0DataRank · unranked

4 citations

Takashi Miwa, Madhu Golla, Wen‐Chao Song, Eshagh Mohammadyari

Improved therapeutic efficacy of a bifunctional anti-C5 mAb-FH SCR1–5 fusion protein over anti-C5 mAb in an accelerated mouse model of C3 glomerulopathy

ImmunoHorizons(2025)10.1093/immhor/vlae006

N/A

0DataRank · unranked

2 citations

Takashi Miwa, Damodar Gullipalli, Madhu Golla, Eshagh Mohammadyari, Lin Zhou +3 more